----
Current ValuationThe current P/E ratio is -31.41, above the reasonable range, cheaper than 14.94% of the time in the past 1 years, and the industry ranks 15/16, the industry Median 15.59.
-31.41xP/E
HK$4.26Stock price
HK$-0.14Earnings per share
-31.41xP/E
Stock priceHK$4.26Earnings per shareHK$-0.14
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- -37.61x
- Typical range
- -59.97x–-33.11x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 15.59x
013263952
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 15.59x
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
02945HKGENSCRIPT B-2K | -15.51x | -- | HK$77.42B |
01548HKGENSCRIPT BIO | -15.04x | 95.09% | HK$75.09B |
02228HKXTALPI | -103.69x | 167.69% | HK$25.18B |
03696HKINSILICO | -9.03x | 100.52% | HK$21.06B |
02576HKTAIMEI TECH | -31.41x | -- | HK$2.36B |
08225HKC HEALTH GP | -4.21x | -- | HK$68.68M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
